Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination.
复制标题
DOI:
10.1038/s41541-022-00583-w
复制
发表时间:
2022-12-10
期刊:
影响因子:
9.2
通讯作者:
中科院分区:
文献类型:
--
作者:
A phase 1 clinical trial to test the immunogenicity of a chimeric group 1 HA (cHA) universal influenza virus vaccine targeting the conserved stalk domain of the hemagglutinin of influenza viruses was carried out. Vaccination with adjuvanted-inactivated vaccines induced high anti-stalk antibody titers. We sought to identify gene expression signatures that correlate with such induction. Messenger-RNA sequencing in whole blood was performed on the peripheral blood of 53 vaccinees. We generated longitudinal data on the peripheral blood of 53 volunteers, at early (days 3 and 7) and late (28 days) time points after priming and boosting with cHAs. Differentially expressed gene analysis showed no differences between placebo and live-attenuated vaccine groups. However, an upregulation of genes involved in innate immune responses and type I interferon signaling was found at day 3 after vaccination with inactivated adjuvanted formulations. Cell type deconvolution analysis revealed a significant enrichment for monocyte markers and different subsets of dendritic cells as mediators for optimal B cell responses and significant increase of anti-stalk antibodies in sera. A significant upregulation of immunoglobulin-related genes was only observed after administration of adjuvanted vaccines (either as primer or booster) with specific induction of anti-stalk IGVH1-69. This approach informed of specific immune signatures that correlate with robust anti-stalk antibody responses, while also helping to understand the regulation of gene expression induced by cHA proteins under different vaccine regimens.
登录
查看更多内容
DOI:
10.1093/cid/cix468
发表时间:
2017-10-15
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Arriola C;Garg S;Anderson EJ;Ryan PA;George A;Zansky SM;Bennett N;Reingold A;Bargsten M;Miller L;Yousey-Hindes K;Tatham L;Bohm SR;Lynfield R;Thomas A;Lindegren ML;Schaffner W;Fry AM;Chaves SS
通讯作者:
Chaves SS
影响因子:
3.7
作者:
Hoek KL;Samir P;Howard LM;Niu X;Prasad N;Galassie A;Liu Q;Allos TM;Floyd KA;Guo Y;Shyr Y;Levy SE;Joyce S;Edwards KM;Link AJ
通讯作者:
Link AJ
影响因子:
30.3
作者:
Eisfeld AJ;Halfmann PJ;Wendler JP;Kyle JE;Burnum-Johnson KE;Peralta Z;Maemura T;Walters KB;Watanabe T;Fukuyama S;Yamashita M;Jacobs JM;Kim YM;Casey CP;Stratton KG;Webb-Robertson BM;Gritsenko MA;Monroe ME;Weitz KK;Shukla AK;Tian M;Neumann G;Reed JL;van Bakel H;Metz TO;Smith RD;Waters KM;N'jai A;Sahr F;Kawaoka Y
通讯作者:
Kawaoka Y
影响因子:
20.3
作者:
Blanchard-Rohner, Geraldine;Pulickal, Anoop S.;Pollard, Andrew J.
通讯作者:
Pollard, Andrew J.
DOI:
10.1038/s41572-018-0002-y
发表时间:
2018-06-28
期刊:
Nature reviews. Disease primers
影响因子:
--
作者:
Krammer F;Smith GJD;Fouchier RAM;Peiris M;Kedzierska K;Doherty PC;Palese P;Shaw ML;Treanor J;Webster RG;García-Sastre A
通讯作者:
García-Sastre A